Visomitin（SKQ1）

Min.Order / FOB Price:Get Latest Price

1 Gram	Negotiable

1 Gram

Negotiable

Min.Order :1 Gram
Purity: 95%(HPLC)
Payment Terms : T/T

Keywords

Visomitin SKQ1 934826-68-3

Quick Details

Appearance:semi-solid
Application:Add antioxidants to cosmetics, prevent eye dryness in eye drops.
PackAge:PTFE bottle
ProductionCapacity:100|Kilogram|Year
Storage:Sealed refrigeration
Transportation:Normal temperature

Superiority:

Name: Visomitin (Synonyms: SKQ1)

CAS number: 934826-68-3

Properties: semi-solid

Purity: 95% HPCL

Properties: Easy to absorb moisture, slightly soluble in water, easily soluble in alcohols

Uses: Add antioxidants to cosmetics, prevent eye dryness in eye drops.

Price: USD 1250 / g; USD 5957 / 10g; USD 20714 / 100g. The price is large and favorable. According to customer requirements, the purity can reach 97%, the price is negotiable.

Details:

Suzhou Yi Peter Biotechnology Co., Ltd. was established in July 2016 with a registered capital of 5 million yuan. It is a high-tech company dedicated to the research, development, production and sales of high-end cosmetic raw materials and new biological materials. Our core technical team is doctors from overseas and domestic biomedicine fields, mastering the core technology of new biomedical materials. The company was rated as Suzhou's leading talent enterprise, and was also rated as a private technology enterprise and a technology-oriented small and medium-sized enterprise. At present, high-level cultivation and storage have been completed. The company already has more than ten invention patents and five utility model patents. The company's products have entered the overseas market, and the goal is to break the monopoly of Japan and the United States in the field of high-end biomaterials. At present, the company has jointly developed a new generation of products with scientific research institutions such as the Shanghai Institute of Organic Chemistry of the Chinese Academy of Sciences, laying the foundation for the company's long-term development.

View All